Clinical Trial Update: A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Flonase® Allergy Relief in Subjects With Allergic Conjunctivitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing Pataday Once Daily Relief Extra Strength to Flonase Allergy Relief in allergic conjunctivitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• Flonase® Allergy Relief (fluticasone)
• Pataday® Once Daily Relief Extra Strength

Snippet

Sponsor: Andover Research Eye Institute | Conditions: Allergic Conjunctivitis | Phase 4 | Status: COMPLETED